Loading...
•
Mar 31, 2024
Multiplan Q1 2024 Earnings Report
Reported first quarter results with revenues of $234.5 million and a net loss of $539.7 million.
Key Takeaways
MultiPlan reported Q1 2024 revenues of $234.5 million, a net loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and adjusted EBITDA of $146.8 million. The company identified potential medical cost savings of approximately $5.7 billion and repurchased or repaid $24.4 million of debt.
Revenues for Q1 2024 were $234.5 million, a decrease of 0.9% compared to Q1 2023.
Net loss for Q1 2024 was $539.7 million, compared to net income of $0.2 million for Q1 2023, primarily due to an impairment charge of $519.1 million.
Adjusted EBITDA for Q1 2024 was $146.8 million, compared to $156.3 million for Q1 2023.
Free Cash Flow of $19.2 million for Q1 2024, compared to Free Cash Flow of $41.1 million for Q1 2023.
Forward Guidance
The Company is maintaining its Full Year 2024 guidance.
Positive Outlook
- Revenues: $1,000 million to $1,030 million
- Adjusted EBITDA: $630 million to $650 million
- Cash flow from operations: $170 million to $200 million
- Q2 2024 revenues between $235 million and $250 million
- Q2 2024 Adjusted EBITDA between $145 million to $160 million
Challenges Ahead
- Interest expense: $320 million to $330 million
- Capital expenditures: $120 million to $130 million
- Depreciation: $80 million to $90 million
- Amortization of intangible assets: $345 million to $350 million
- Effective tax rate: 25% to 28%
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...